https://orcid.org/0000-0002-5234-9787
Figures & data
Table 1 Targeted CD47/SIRPα Antibody Research in Recent Years
Figure 1 The timeline of the key discoveries.
Figure 2 (A) CD47-SIRPɑ interaction blocks macrophage phagocytosis of cancer cells. (B) Treatment of cancer cells treated with anti-CD47/SIRPɑ Ab induces phagocytosis by macrophage.
Figure 3 The value of CD47 in the diagnosis, treatment, and prognosis assessment of various tumors.
